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dynamics of phospholipid membranes by means of quasi-elastic neutron scattering in the picosecond time-
scale. Samples of pure phospholipids (DMPC/DMPS) and samples with amyloid-β (25–35) peptide included
have been compared. With two different orientations of the samples the directional dependence of the
dynamics was probed. The sample temperature was varied between 290 K and 320 K to cover both the gel
phase and the liquid-crystalline phase of the lipid membranes. The model for describing the dynamics
combines a long-range translational diffusion of the lipid molecules and a spatially restricted diffusive
motion. Amyloid-β (25–35) peptide affects signiﬁcantly the ps-dynamics of oriented lipid membranes in
different ways. It accelerates the lateral diffusion especially in the liquid-crystalline phase. This is very
important for all kinds of protein–protein interactions which are enabled and strongly inﬂuenced by the
lateral diffusion such as signal and energy transducing cascades. Amyloid-β (25–35) peptide also increases
the local lipid mobility as probed by variations of the vibrational motions with a larger effect in the out-of-
plane direction. Thus, the insertion of amyloid-β (25–35) peptide changes not only the structure of
phospholipid membranes as previously demonstrated by us employing neutron diffraction (disordering
effect on the mosaicity of the lipid bilayer system) but also the dynamics inside the membranes. The
amyloid-β (25–35) peptide induced membrane alteration even at only 3 mol% might be involved in the
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Amyloid-β peptides (Aβ) are the main constituent of senile
plaques which are a pathological hallmark in Alzheimer's disease.
To date the ﬁbrillar “amyloid hypothesis” dominates the research
about the origin of the dementia, suggesting that Aβ plaques are the
cause of the disease [1,2]. Only recently attention has become focused
on pre-ﬁbrillar monomeric Aβ and small oligomers of Aβ as an origin
of Alzheimer's disease [3]. Unlike senile plaques, Aβ monomers and
oligomers are water soluble and membrane active [4].The neurotoxic fragment Aβ (25–35) is a membrane active
peptide representing the membrane spanning domain of the amyloid
precursor protein (APP) and of the full-length peptide Aβwith 39–42
amino acids which occurs in Alzheimer affected brains with 39–42
amino acids. It is thought to represent the main responsible region for
the neurotoxic effect of Aβ (1–42) even though only a part of the
mechanisms driving the toxicological properties is active in the
truncated peptide, but it causes an increased and faster oxidative
damage than the full-length peptide Aβ (1–42) [5].
Neutron scattering techniques are perfectly suitable for probing
the physical properties of biological proteins and membranes (cf. for
example [6] for a review, [7–11], and references therein). They are
particularly able to reveal structural and dynamic information about
the interaction of Aβ with lipid membranes of different composition.
Previously, our group has performed several investigations on Aβ-
membrane interaction with neutron diffraction and small angle
neutron scattering [12]: The fragment Aβ (25–35) is capable of
intercalating into lipid bilayers. Investigations regarding the localiza-
tion of Aβ (25–35) in phospholipid membranes revealed that the
deuterated leucine at position 34 is deeply inserted into the lipid
bilayer [13], and could be located in the center region of the lipid alkyl
Fig. 1. Structure of Aβ (1–42) in aqueous solution (PDB ID: 1IYT) with the neurotoxic
fragment Aβ (25–35) highlighted and indicated by an arrow, created after [14,15].
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intercalated Aβ (25–35) (the polar head region of the membrane is
broadened, while the inner part is heavily perturbed). It has a
disordering effect on the long-range lamellar order of the lipid bilayer
system (the mosaicity determined by the ﬁrst order Bragg peak
increases from 0.5° to 8.5° (FWHM) due to the insertion of Aβ (25–
35)) [15]. The membrane composition (charge of head groups,
cholesterol content) modulates the extent and depth of insertion of
Aβ (25–35) into the membrane. A cholesterol content of 5 mol% and
above prevents the intercalation of Aβ (25–35) while the membrane
structure is maintained [16]. Moreover, Aβ (1–42) oligomers with
1 mol% concentration displace the cholesterol in POPC/cholesterol
model membranes towards the lipid head groups [17].
The physiological long-chain peptide also intercalates deeply into
the lipid bilayer as revealed by a small angle neutron scattering study
on Aβ (1–42) which showed furthermore that it destabilizes the
membrane and induces membrane fusion [18].
In the present investigation, we demonstrate that Aβ (25–35)
affects signiﬁcantly the dynamics of phospholipid DMPC/DMPS
membranes, mainly resulting in a faster lateral diffusion of the lipids
inside the membrane, especially in the biologically relevant liquid-
crystalline phase. As almost all kinds of protein–protein and protein–
lipid interactions in membranes are enabled and strongly inﬂuenced
by lateral diffusion processes, the increase of the lateral diffusion
coefﬁcient of the lipid molecules is of high relevance. The inﬂuence on
all these kinds of interaction is explained by the “ﬂuid mosaic model”
of biological membranes by Singer and Nicolson [19] according to
which proteins and peptides are “swimming” in a two-dimensional
liquid of lipid molecules and they canmore or less freely diffuse in the
membrane layer. Furthermore, lipid rafts (i.e. membrane microdo-
mains), for example, play a functional role in cell membranes, en-
suring correct intracellular compartmentation, protein–protein
interaction and trafﬁcking of proteins and lipids. Their disruption is
often related to diseases and aging [20,21].
Thus, our results could be a clue to understand the pathological
effect of Aβ to trigger Alzheimer's disease, for early diagnosis, and to
design anti-Alzheimer's disease treatment.
2. Materials and methods
2.1. Sample description
Two types of samples were prepared, pure phospholipid samples
and samples with amyloid-β (25–35) peptide included, respectively.
The pure phospholipid sample (200 mg) was prepared as a 92:8 mol%
mixture of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)
and 1,2-dimyristoyl-sn-glycero-3-phospho-L-serine (DMPS) (pur-
chased from Avanti Polar Lipids). The small amount of DMPS was
used in order to get a negatively charged phospholipid membrane to
mimic the net-negative charge of cell membranes. Both lipids were
separately dissolved in a 2:1 chloroform/methanol solution and then
mixed.
The amyloid-β (25–35) peptide (H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-
Ile-Gly-Leu-Met-OH) was synthesized and puriﬁed to more than 98%
(determined by high performance liquid chromatography) by WITA
GmbH (Teltow, Germany). (Fig. 1 displays the full-length peptide Aβ
(1–42) with the employed fragment Aβ (25–35) highlighted. Figure
created after [22,23] (PDB ID: 1IYT) with PyMol [24].)
For the Aβ samples an amount of 10 mg Aβ (25–35) peptide was
dissolved in chloroform and then added to the lipid solution (190 mg
lipids) which yields a concentration of 3 mol%. This low concentration
of Aβ (25–35) peptide was used in order to keep the structure of the
phospholipid membranes basically unaffected (almost no change in
mosaicity) but it was sufﬁcient to cause an effect on the dynamics of
the membrane. This effect was large enough to be detected by quasi-
elastic neutron scattering. Additionally, the Aβ (25–35) concentrationwas also small enough to observe only the scattering contributions of
the lipid phase and not of the Aβ (25–35) peptide itself (cf. Section 4).
In order to maintain the peptide in its monomeric form and to
avoid any pre-aggregation before the addition into themembrane, the
peptide was pretreated with triﬂuoroacetic acid (TFA) according to
[25]. The peptide/TFA solution was dried in a quartz tube under a
stream of nitrogen and then dried in vacuum (p=1mbar) for 12 h to
remove all traces of TFA (for more details refer to [13]). Afterwards,
the peptide was dissolved in chloroform and then mixed with the
lipid solution.
Oriented membrane samples were prepared by spraying this
mixed solution (10 ml) with an airbrush onto thin aluminum disks
(thickness: 0.25 mm, diameter: 5 cm) which were used as substrates.
The solvent was completely removed by drying the samples for 12 h
in a vacuum desiccator at a pressure of about 1 mbar. Afterwards, the
samples were rehydrated for 24 h in an atmosphere at 98% relative
humidity (r.h.) controlled by a saturated K2SO4/D2O salt solution. This
procedure resulted in a water content of 22 wt% (determined by
weighing the hydrated samples and, after the experiment, the sub-
sequently dried samples) corresponding to approximately 11 water
molecules per lipid molecule.
The oriented samples were enclosed in disk-shaped sealed
aluminum sample containers in order to maintain the humidity
during the experiment.
For the dynamic investigations D2O was used for hydration to
suppress incoherent scattering from the solvent. Thus, the neutron
scattering signal originates almost completely from the membrane
itself, i.e., predominantly from the phospholipids.2.2. Neutron diffraction
The ordering (mosaicity) of the samples has been checked with
neutron diffraction at the membrane diffractometer V1 (Helmholtz–
Zentrum Berlin). The mosaicity was measured by rocking the sample
around the ﬁrst order Bragg peak (2θ=5.2°) by ω=±20° revealing a
very similar but broad distribution for both samples with and without
Aβ (25–35) peptide resulting in a mosaicity of FWHM ~ 30°. This
means the samples have a well-deﬁned lamellar order with a deﬁned
layer distance (determined by the 2θ-position of the Bragg peaks) but
a relatively high mosaicity. This is mainly due to the large sample
amount (200 mg) required for the dynamic investigations with quasi-
elastic neutron scattering compared to the typical sample amount
(10 mg) for neutron diffraction experiments in [13], resulting in a 10
times higher sample thickness.
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by measuring the in-plane correlation peak, which gives information
about the lipid–lipid correlations. The results have been used for the
evaluation of the phase transition temperatures.
2.3. Quasi-elastic neutron scattering
The quasi-elastic neutron scattering (QENS) measurements were
performed at the time-of-ﬂight spectrometer NEAT at the Helmholtz–
Zentrum Berlin für Materialien und Energie [26].
The sample orientation was 45° and 135°, respectively, with respect
to the incident beam, as outlined in Fig. 2. With these two different
orientations it was possible to probe the membrane dynamics in two
different directions: “out-of-plane” for 45° orientation (where the
resulting Q vector is parallel to the membrane normal) and “in-plane”
for 135° orientation (where Q is perpendicular to the membrane
normal). Although this holds true only for a scattering angle of 2θ=90°
it is possible to monitor orientation dependencies when the data are
averaged over the (available) scattering angles (2θ=13°−136°)
because a larger amount of the scattering signal originates from the
present preferential orientation.
An experimental resolution (full width at half maximum) of
ΔE=93 μeV with a wavelength of λ=5.1 Å was used. The data were
corrected for the contribution of the empty container and the different
detector efﬁciencies. A standard vanadium disk of 1 mm thickness
was measured to determine the experimental resolution function,
which is an almost perfect Gaussian function for NEAT at reasonable
resolution values.
For data analysis, the resolution function was analytically
convoluted with the theoretical scattering function, giving higher
accuracy than for numerical convolution. For all corrections, standard
routines included in the program package FITMO from NEAT were
applied [27]. To increase the statistics, the data have been binned into
5 angular groups before the transformation to the energy scale
(Q=0.4−2.2 Å). Because of large transmission values of TN0.9, it was
not necessary to correct for multiple scattering.
The temperature was varied in the range between 290 K and 320 K,
with an accuracyof 0.1 K. This temperature range covers themain phase
transition temperatures of DMPC at 297 K [28] and DMPS at 309 K [29].
3. Theory
The dynamic properties of the membranes were investigated by
quasi-elastic incoherent neutron scattering.Fig. 2. Experimental orientations and resulting Q vectors: thick black arrows: direction
of incident neutrons, parallel lines: lipid bilayer membrane stacks, dashed lines:
membrane normal, bars: substrate, thin arrows: incident and scattered wave vector and
resulting scattering vector Q , respectively (the angle of the sample orientation is also
marked).We restrict ourselves to the discussion of incoherent scattering
since hydrogen atoms (of the lipids and Aβ) scatter mainly in-
coherently and the rather small coherent contributions can be
neglected. This is also valid for the small contribution from the
coherent scattering of the solvent D2O.
The dynamics of the hydrogen atoms reﬂects the dynamics of
larger groups they are attached to, such as lipid tails and head groups.
Using the Van Hove formalism [30] the incoherent scattering
function S(Q,ω) provides information about the dynamics of
(hydrogen) atoms. The dynamics was analyzed by use of the general
theoretical incoherent scattering function [31]:
StheoðQ ;ωÞ = e−〈u
2〉Q2 A0ðQÞ⋅δðωÞ + ∑
n
AnðQÞ⋅LnðΓn;ωÞ
 
ð1Þ
(the formula is used in isotropic approximation without taking into
account specialmotions of certain atoms). The scattered intensity S(Q,ω)
is separated into anelastic δ-shapedcomponent andanumbernof quasi-
elastic Lorentzian-shaped contributions parameterized by the half width
Γn=1/τn (τn: time constant of the motion) and the quasi-elastic
incoherent structure factors An (QISF). The amplitude of the elastic
component is given by the elastic incoherent structure factor (EISF) A0.
The Debye–Waller factor e− 〈u
2 〉Q2 describes the contributions due to
thermal vibrations, where 〈u2〉 represents the global averaged mean
square displacement (MSD) of the vibrational motions [32].
The theoretical scattering function Stheo(Q,ω) has to be convoluted
with the resolution function Sresol(Q,ω) to get a function which can be
used for ﬁtting the measured scattering data:
SmeasuredðQ ;ωÞ = F ⋅e
−
ℏω
2kBT StheoðQ ;ωÞ⊗SresolðQ ;ωÞ½  ð2Þ
where e
−
ℏω
2kBT is the detailed balance factor and F a normalization
factor.
4. Results and discussion
Three important parameters have been varied during the dynamic
experiments with quasi-elastic neutron scattering (QENS): sample
composition (pure phospholipid samples versus sampleswith Aβ (25–
35) included), sample orientation (to probe in-plane and out-of-plane
dynamics) and sample temperature (290 K–320 K, which covers the
phase transition temperature of the sample main constituent: DMPC),
see Materials and methods for details. (In the following, the peptide
fragment Aβ (25–35) will be denoted as Aβ only.)
Fig. 3a shows a typical experimental scattering function S(Q ,ω)
with quasi-elastic broadening (in the vicinity of the elastic peak at
E=0meV) for an Aβ-containing sample at 315 K. For comparison,
also the experimental resolution function is drawn.
The data have been analyzed starting with a purely phenomenolog-
ical model with two Lorentzian contributions: a slower Q-dependent
motion (“slowmotion”, time scale: 14 ps) and a faster notQ-dependent
motion (“fast motion”, time scale: 4 ps), see Fig. 3b for an example. For
all samples and all temperatures a model with these two contributions
was sufﬁcient to describe the experimental data appropriately with
continuously varying parameters (while a model with only one
Lorentzian contribution did not sufﬁce).
From the analysis of the results of the phenomenological model we
derived stepwise amore appropriate model with physical justiﬁcation
which will be explained in detail in the following. Eq. (1) changes to
StheoðQ ;ωÞ = e−〈u
2〉Q2 ½Sslow ⊗ Sfast ð3Þ
where ⊗ again describes a convolution.
All resulting ﬁt parameters exhibit a relative error between 1 % and
5 %, i.e., the size of the error is in all cases smaller than the size of the
Fig. 3. Measured incoherent scattering function S(Q,ω) of an “Aβ+lipids” sample at
315 K with experimental resolution function included (a) and the same function with
quasi-elastic region enlarged with two Lorentzian contributions (b), data summed over
all Q.
Fig. 4. Mean square displacement 〈u2〉 in dependence of temperature and orientation:
information about the thermal vibrational motions in the membranes (solid symbols:
Aβ+lipids, open symbols: pure lipids, squares: orientation 45°, circles: orientation
135°, lines are guides for the eye).
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graphs.4.1. Mean square displacement
Themean square displacement 〈u2〉 (MSD) (cf. equation (1)) repre-
sents the amplitude of the thermal vibrational motions in the lipid
bilayer system. The experimentally covered MSD range is about
〈u2〉 = 0:01−25 Å2, resulting from the available Q-range and Q-
resolution.
The two samples at two different orientations exhibit signiﬁcant
differences (Fig. 4). (The values have been determined by ﬁtting the
data with equation (2).)
First of all, the vibrational dynamics (as shown by the MSD) is
larger for the out-of-plane (45°) direction as compared to the in-plane
direction (135°). The presence of Aβ increases the lipid ﬂexibility for
both directions. This effect is even larger for the out-of-plane motion.
Thus, we conclude that the addition of Aβ affects signiﬁcantly the
oriented membrane dynamics.
A similar behavior of the mean square displacement has been
described for a membrane protein which partly intercalates into lipid
membranes: MBP (myelin basic protein) in DMPA (1,2-dimyristoyl-
sn-glycero-3-phosphate) membranes [33].
Thus, the addition of peptides and proteins to phospholipid
membranes can change the physical properties of the membrane in
such a way, that the local ﬂexibility of the lipid molecules increases
and vibrational motions with larger amplitudes are enabled.4.2. Slow motion (time scale: ∼14 ps)
The ﬁrst applied phenomenological model revealed that the slow
motion is Q-dependent, actually the half width Γslow (cf. equation (1))
of the Lorentzian contribution shows a Q2-dependence. Therefore, this
slow motion contribution was more precisely described with a
translational diffusionmodel [31], in which the theoretical incoherent
scattering function is given by
SslowðQ ;ωÞ =
1
π
⋅ DLQ
2
ω2 + ðDLQ2Þ2
; ð4Þ
which is a Lorentzian function with half width Γslow=DLQ2.
The experimentally determined lateral diffusion coefﬁcient DL
exhibits a distinct behavior for the two different samples at the two
orientations, as shown in Fig. 5.
The lateral diffusion coefﬁcient is clearly direction dependent, i.e.
themotion is faster for the in-plane conﬁguration (135°), compare the
higher DL values for this direction (circles in Fig. 5).
The available Q range (0.4–2.2 Å−1) where this translational
motion was observed corresponds to a length scale of up to 16 Å in
real space.
In summary, we conclude that this motion is an in-plane long
range translational diffusion of entire lipid molecules.
The diffusion coefﬁcient is higher for samples with Aβ included
both in the gel phase and in the liquid-crystalline phase (solid symbols
in Fig. 5, gel phase: negative values of T−Tc, liquid phase: positive
values). Only in the region of the phase transition (T−Tc ~ 0 K) we
found some small overlap of the diffusion coefﬁcients for both types of
samples.
The value of the diffusion coefﬁcient (DL=5−18×10−11 m2/s at
T=290−320 K for DMPC/DMPS membrane sample) is in good
agreement with the quasi-elastic neutron scattering results found by
Tabony et al. [34] for 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC) membranes (DL=1.4−12×10−11 m2/s at T=302−328 K,
with main phase transition temperature Tc=314 K). In contrast to
this, various other studies report signiﬁcantly lower lateral diffusion
coefﬁcients for phospholipid membranes (factor 10 smaller, see for
example [35]: DL=5.8×10−12 m2/s for DMPC at 298 K, [36] and
references cited therein). However, those values were determined
with methods such as NMR spectroscopy, EPR and ﬂuorescence
techniques which observe greater distances and longer times
compared to QENS, while the QENS ranges correspond to the ones
involved in molecular diffusion [34].
Fig. 5. Lateral diffusion coefﬁcient DL (ﬁtted data) in dependence of relative
temperature T−Tc, where the phase transition temperature Tc has been determined
by in-plane neutron diffraction (cf. Fig. 6) (solid symbols: Aβ+lipids, open symbols:
pure lipids, squares: orientation 45°, circles: orientation 135°, lines are guides for the
eye).
Fig. 6. Temperature dependence of the intensity of the in-plane correlation peak at
Q ~ 1.5 Å−1 from diffraction measurements at the membrane diffractometer V1
(Helmholtz–Zentrum Berlin) for samples with Aβ (squares) and without Aβ (circles).
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of Aβ is supported by ﬁndings from Lau et. al [37], who suggested a
reduction in membrane stability (with NMR spectroscopy) and an
increase in membrane ﬂuidity (with ﬂuorescence spectroscopy) for
samples inwhich Aβ (1–42) was incorporated into lipid d-POPC/POPS
bilayers.
In contrast, Müller et al. [38] noted a concentration-dependent
decrease of membrane ﬂuidity upon Aβ (25–35) interaction in natural
membranes from mouse and rat brains, while the scrambled peptide
Aβ (35–25) did not show any inﬂuence. Furthermore, reports about
the inﬂuence of other membrane intercalated peptides on the lateral
diffusion in different phospholipid membranes with NMR methods
demonstrated a decrease of the lateral diffusion coefﬁcient in the
membranes with peptide compared to the pure phospholipid
samples, see for example [39] (gramicidin D in DMPC) and [40]
(WALP16 (Ac-Gly-Trp-Trp-Leu-Ala-Leu-Ala-Leu-Ala-Leu-Ala-Leu-
Ala-Trp-Trp-Ala-CONH2) in POPC (1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine)).
Hence, the increase of the lateral diffusion coefﬁcient induced by
Aβ observed in the present study seems to be characteristic for the
Alzheimer's peptide in phospholipid model membranes.
The different behavior reported for other peptides and Aβ in
natural membranes could (partly) also be related to the different time
and distances scales of NMR and neutron scattering methods.
The molecular mechanism of changing the membrane ﬂuidity and
ﬂexibility by Aβ is still unclear and should be clariﬁed in future ex-
periments, especially in native brain membrane samples.
The lateral diffusion coefﬁcient DL increases with increasing tem-
perature, as expected (Fig. 5). For the pure lipid samples the phase
transition occurs at around 300 K, and it is largely smeared out for the
samples containing Aβ. Additionally, the phase transition tempera-
ture increases for the Aβ containing samples.
This behavior of the phase transition temperature was observed in
structure information from in-plane diffraction as revealed by the in-
plane correlation peak which describes the crystalline in-plane order
of the lipid chains (lipid–lipid correlations). Fig. 6 depicts the
intensities of the in-plane correlation peak at Q ~ 1.5 Å−1 for the
pure lipid sample and the sample with Aβ. The experimental data
have been ﬁtted with the sigmoidal Boltzmann function
intensity = C2 +
C1−C2
1 + ebðT−TcÞ
; ð5Þwhich yields a phase transition temperature Tc of 302.5 K and 305.5 K
for the pure lipid sample and the sample with Aβ included, re-
spectively (C1, C2, b and Tc are the ﬁt parameters).
The phase transition temperature of the DMPC/DMPS sample is
about 5.5 K higher than the values reported for pure DMPC [28]
(Tc=297 K). The main reasons for this difference are the lower
relative humidity of the samples used by us (98% r.h.) compared to
fully hydrated samples (100% r.h.), which yields a shift of about 0.9 K
([41]) and the presence of 8 mol% DMPS (Tc=309 K, cf. [29]) which
also shifts the phase transition temperature about 0.7 K to higher
values [42]. The remaining difference should be due to the speciﬁc
bilayer structure of our samples. The interactions of the lipid bilayer
system with the substrate can be neglected due to the very high
number of bilayers in our samples (several thousand).
The change in the behavior of the phase transition under the
inﬂuence of Aβ (increase of Tc and broadening of the width) is similar
to effects described for other hydrophobic peptides which penetrate
into phospholipid bilayers and especially DMPCmembranes ([29,43]).
(The penetration of Aβ into membranes has been previously proven
[13,14].)
Overall we can state that the addition of Aβ accelerates the lateral
diffusion of entire lipidmolecules in both investigated phases (gel and
liquid-crystalline phase) of the lipid bilayers, but more pronounced in
the liquid-crystalline phase above the phase transition.
This effect can play a crucial role in the process of the Alzheimer's
disease because the lateral diffusion in lipid bilayer systems inﬂuences
not only the lateral motion of the lipid molecules but also of the
proteins and therefore affects all kinds of protein–protein, protein–
lipid and lipid–lipid interactions, which is of importance for all signal
and energy-transducing cascades in membranes. It will, e.g., effect the
processing of the amyloid precursor protein APP by β- and γ-secretase
and inﬂuence the signal-transduction at the pre- and post-synaptic
membrane, cf. [44] for a detailed description of the relevant pathways
of APP processing in Alzheimer's disease affected brains.
4.3. Fast motion (time scale: ∼ 4 ps)
For the secondmotion in the membrane system, the fast motion, it
was only possible to use a phenomenological description with one
Lorentzian function. Thus, the theoretical scattering function Sfast
combines an elastic peak and a Lorentz function Lfast:
SfastðQ ;ωÞ = A0ðQÞδðωÞ + ð1−A1ðQÞÞ × LfastðQ ;ωÞ; ð6Þ
1974 A. Buchsteiner et al. / Biochimica et Biophysica Acta 1798 (2010) 1969–1976where A0(Q) and A1(Q) are the elastic and the quasi-elastic structure
factor, respectively.
The analysis of the elastic incoherent structure factor (EISF) A0 (see
Fig. 7a for the ﬁt data) shows for all temperatures a qualitatively
similar behavior. As the curves overlap for all types of samples, one
can conclude that there is no detectable inﬂuence of Aβ.
Regarding a deeper analysis of the origin of this motion: It is
remarkable that the EISF does not reach 0 for higher Q-values
(although theminimum value is almost reached at Q ~ 2.2 Å−1) which
rules out all models describing rotational motions with ﬁxed centers
of rotation (see, for example, [31] for different possible models).
The width Γfast(Q,ω) (HWHM) of the Lorentzian contribution
exhibits two important features, see Fig. 7b. It is not proportional to Q2
and does not reach the zero limit for Q=0. This excludes all long-
range translational diffusion models. Γfast(Q,ω) is also not constant
with Q, thus, the motion is not a completely localized motion such as
rotations, etc., would be.
From theseﬁndingswe suggest that thismotion could be any kind of
a spatially restricted diffusion, such as diffusion in cylinders or spheres,
chain defectmotions, kink diffusion etc. Although these kind ofmotions
have been described previously (diffusion in a cylinder [45], diffusion in
a sphere [46] and others) there is no analytical model available to date
which can be applied to ﬁt themeasured experimental data. König et al.
[47] used a model for local diffusion in a cylinder to describe the
dynamics in DPPC bilayers, but the model operates adequately only if a
size distribution of the cylinder dimensions is taken into account which
makes the model quite arbitrary.Fig. 7. EISF A0 at two different temperatures of samples with and without Aβ and
orientations of 45° and 135°, respectively (a); half width at half maximum Γfast
(HWHM) of the Lorentzian contribution describing the fast motion (b); (the lines are
guides for the eye).As the EISF, also the HWHM Γfast does not show any inﬂuence of
the Aβ present (compare the solid and open symbols in Fig. 7b). Also
the orientation exhibits solely in the range of the phase transition a
small difference (see squares and circles in Fig. 7b). Both ﬁndings lead
to the conclusion that the Aβ-molecules are too sparsely distributed in
the lipid membrane to result in any distinct effect on a more or less
localized motion. (Of course, at the positions in the membrane where
an Aβ-molecule is located, one would also have an effect on the
localized (fast) motion, but this scattering contribution was too small
for detection.)
All the considerations discussed above only hold if one does not
take into account any ﬁxed scatterers in the samples, i.e., atomswhich
are completely hindered from any motions but thermally induced
vibrational ones. Due to the organic nature of the samples and the
moderate temperature range this condition is justiﬁed.
In order tomonitor the phase transition between the gel phase and
the liquid-crystalline phase we analyzed the behavior of the dynamics
with respect to temperature in a range from 290 K to 320 K.
It turned out that all ﬁt parameters change continuously with
temperature, i.e., there are no steps or discontinuities apparent.
Therefore it is not appropriate to use completely different models for
the gel phase and the liquid-crystalline phase.
The EISF decreases with increasing temperature, i.e., the quasi-
elastic contribution gets more pronounced (Fig. 8a). This indicates
that the lipid molecules become more ﬂexible and more mobile with
increasing temperature.
The fastmotion gets fasterwith increasing temperature as revealed
by the increasing width Γfast, especially at higher Q (Fig. 8b). It is
remarkable that not only thewidth changeswith temperature, but alsoFig. 8. Temperature dependence of EISF A0 (a) and HWHM Γfast (b).
1975A. Buchsteiner et al. / Biochimica et Biophysica Acta 1798 (2010) 1969–1976the slope of the function. This increasing slope of the curve could
indicate a continuous change of the geometry and size of the re-
stricting volume.
Apart from the describedmotions also othermovements should be
present in the system, for example rotational motions of lipid mol-
ecules around their long axis etc., but apparently their time scales lie
outside of the available time window (0.7 ps – 14 ps) (compare for
instance the time constants for rotational diffusion of entire lipid
molecules from [48] DR=5.6×1010 s−1 which corresponds to 17 ps
or for kink diffusion: ~ 20 ps [49]) or their scattering intensities are to
small to get detected. Although those kind of motions are not very
much slower than the discussed ones (long-range lateral diffusion,
localized diffusion) their contribution cannot be resolved with the
experimental resolution used.
5. Conclusions
This is the ﬁrst demonstration that the Alzheimer's peptide Aβ
(25–35) inﬂuences signiﬁcantly the ps-dynamics of phospholipid
membranes which are a relevant model of biological membranes.
Noteworthy, Aβ (25–35) increases the lateral diffusion coefﬁcient
especially in the liquid-crystalline phase (increase by up to 20%).
Thus, it affects all kinds of interactions between proteins and lipids in
the biologically relevant phase above the phase transition tempera-
ture. The change of the lateral diffusion could have great importance
regarding the onset of Alzheimer's disease and for the prevention of it.
This is not only because some lipids act as signal transmitter (second
messengers) in membranes, but also all other membrane based signal
cascades as well as energy conversion at the inner mitochondrial
membrane inherently depend on lateral diffusion and mobility of
lipids and proteins.
Aβ (25–35) also increases the short-range ﬂexibility of the lipid
membrane as probed by the mean square displacement represented
by the thermally activated vibrational motions in the system. This
effect is larger in the out-of-plane conﬁguration than in the in-plane
conﬁguration.
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